Nephroplus
Live Price
Recent news and updates for NEPHROPLUS will appear here soon.
"Balanced market signals for NEPHROPLUS. The stock is currently consolidating with neutral technical indicators and fundamental alignment between current healthcare growth rates and prevailing valuation metrics."
Verified by Stockmo Intelligence Grid
Citing cross-referenced internal documents and market technicals
Nephrocare Health Services Limited operates a chain of kidney care clinics that provides dialysis healthcare services with dialysis centres in India, Uzbekistan, Nepal, Kingdom of Saudi Arabia, and the Philippines. It provides In-clinic dialysis, dialysis on call, home hemodialysis, holiday dialysis, and dialysis on wheels services. Nephrocare Health Services Limited was incorporated in 2009 and is based in Hyderabad, India.
As of the latest market session, Nephroplus (NEPHROPLUS) is trading at ₹688.75, representing a move of 1.04% from the previous close.
Nephroplus is listed and traded under the ticker symbol NEPHROPLUS on the National Stock Exchange of India (NSE) and Bombay Stock Exchange (BSE).
Today, Nephroplus's stock price moved by 1.04%. Long-term growth trends depend on company financials, technical moving averages, and sector momentum in the Healthcare industry.
Our proprietary AI Momentum engine calculates a 77% bullish probability for NEPHROPLUS stock over the next 3-5 days. View the live interactive chart on Stockmo to see dynamic technical forecasting.
Over the past 52 weeks, Nephroplus shares reached a high of ₹769.75 and hit a low of ₹446.
NEPHROPLUS exhibits standard volatility for a Healthcare stock, with an average daily trading volume of 1,00,842 shares. Detailed technical beta indicators are available on the Stockmo charting engine.
Nephroplus has a market capitalization of ₹6926.00 Cr, designating its size class inside the Healthcare sector.
Nephroplus has a current dividend yield of N/A. Companies may adjust payout ratios depending on quarterly earnings growth and reinvestment opportunities.
Nephroplus's trailing Price-to-Earnings (P/E) ratio is 84.93. This indicates how much investors are willing to pay for every rupee of the company's annual net earnings.
You can purchase Nephroplus (NEPHROPLUS) shares through any SEBI-registered stockbroker (such as Kite/Zerodha, Groww, or Angel One) by funding your trading account and executing a buy order on the NSE or BSE.
Nephroplus's financial health, solvency, growth, and quality metrics are tracked using our proprietary Multibagger V2 score. You can explore NEPHROPLUS's detailed 5-tier financial scorecard and compare it with market competitors on the Stockmo Multibagger Screener page.
Institutional order blocks and pristine support/resistance triggers for NEPHROPLUS are monitored in real-time. View live technical entry levels, stop loss bounds, and target prices on our interactive Supply & Demand Trading Engine or scan entire market segments using the Basket Scanner.
Nephroplus operates inside the Healthcare sector. You can analyze sector-wide trends, relative strengths, and locate top emerging leaders in this space using our Sector Analysis Hub.